Introduction
How the size of an organ is controlled has remained an unsolved mystery in development biology. The organ size is mainly determined by the number and size of its constituent cells, and both extrinsic environmental factors such as hormones and nutrients and intrinsic growth-control mechanisms contribute to the control of tissue growth by coordinately regulating cell growth, cell proliferation and cell apoptosis (Bryant and Simpson, 1984; Conlon and Raff, 1999) . Genetic screens in Drosophila have identified a large number of tumor suppressor genes, mutations of which result in overgrowth of imaginal disc derivatives (Hariharan and Bilder, 2006) . Several tumor suppressor genes, including warts (wts) (Justice et al., 1995; Xu et al., 1995) , salvador (sav) (Tapon et al., 2002) and hpo (also called dMST) (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) , fat (Bennett and Harvey, 2006; Cho et al., 2006; Mahoney et al., 1991; Silva et al., 2006; Willecke et al., 2006) and expanded (ex) (Cho et al., 2006; Hamaratoglu et al., 2006; Maitra et al., 2006; Pellock et al., 2007) define a common tumor suppressor pathway, the socalled Hpo pathway (Pan, 2007; Zhang et al., 2009) .
The Hpo pathway regulates tissue growth and organ size by inhibiting cell growth and proliferation as well as by promoting apoptosis through modulating the expression of genes including cyclin E, diap1 and bantam that are involved in these cellular processes (Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003; Tapon et al., 2002; Thompson and Cohen, 2006; Udan et al., 2003; Wu et al., 2003) . The core components of the Hpo pathway, Hpo, Sav, Wts and Mats, constitute a kinase cascade. The upstream kinase Hpo, the Drosophila homolog of mammalian Ste20 family kinases MST1 and MST2, associates with the WW-domain containing scaffolding protein Sav to phosphorylate and activate the downstream kinase Wts, which belongs to the nuclear Dbf-2-related (NDR) kinase family (Harvey et al., 2003; Jia et al., 2003; Justice et al., 1995; Pantalacci et al., 2003; Tapon et al., 2002; Udan et al., 2003; Wu et al., 2003; Xu et al., 1995) . The phosphorylated Wts interacts with a cofactor Mats, which is also phosphorylated by Hpo (Lai et al., 2005; Wei et al., 2007) , to regulate the expression of Hpo pathway target genes by phosphorylating a transcriptional coactivator Yki, the Drosophila homolog of Yap (Huang et al., 2005) .
Recently, the TEAD/TEF family transcription factor Scalloped (Sd) has been implicated as a transcription factor for the Hpo pathway. Sd both genetically and physically interacts with Yki and is essential for tissue overgrowth induced by Yki overexpression or by loss of Hpo or Wts (Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008) . Sd binds to the enhancer elements of diap1 (Wu et al., 2008; Zhang et al., 2008) . In addition, Sd promotes nuclear localization of Yki and recruits Yki to the diap1 promoter (Zhang et al., 2008) . On the other hand, phosphorylation of Yki at Ser168 by Hpo signaling restricts Yki nuclear Developmental Biology 337 (2010) Contents lists available at ScienceDirect Developmental Biology j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / d e v e l o p m e n t a l b i o l o g y localization (Dong et al., 2007; Oh and Irvine, 2008; Zhang et al., 2008) . Mutating Ser168 to Ala promotes Yki nuclear localization and its ability to induce tissue overgrowth when overexpressed in vivo and rendered Yki more resistant to Hpo-mediated repression (Dong et al., 2007; Oh and Irvine, 2008; Zhang et al., 2008) . Similarly, mutating the corresponding Ser residue in Yap (Ser127) promoted Yap nuclear localization and activity and rendered Yap more resistant to Latsmediated inhibition (Hao et al., 2008; Zhao et al., 2007) . In response to Hpo signaling, Yki/Yap interacted with 14-3-3 whereas YkiS168A/ YapS127A failed to bind 14-3-3 (Dong et al., 2007; Oh and Irvine, 2008; Zhao et al., 2007) . As 14-3-3 binding often regulate protein subcellular localization including nuclear/cytoplasmic shuttling (Fu et al., 2000) , these observations imply that phosphorylation of Yki/Yap at S168/ S127 restrict their nuclear localization by promoting 14-3-3 binding. However, genetic evidence for the involvement of 14-3-3 in the Hpo pathway and in regulating Yki /Yap nuclear localization is still lacking. 14-3-3 proteins are highly conserved and ubiquitously expressed phosphor-S/T binding proteins. 14-3-3 proteins form homo-and hetero-dimers and participate in many cellular processes including signal transduction through binding to specific phosphorylated sites on their target partners (Mackintosh, 2004; Morrison, 2009 ). There are two isoforms of 14-3-3 in Drosophila, 14-3-3ɛ and 14-3-3ζ/ Leonardo that often act redundantly in many cellular processes (Acevedo et al., 2007; Benton and St Johnston, 2003) . Here we provide evidence that both 14-3-3 isoforms are involved in modulating Yki activity through regulating its subcellular localization. We showed that inactivating 14-3-3 either by RNAi knockdown or genetic mutations enhanced tissue overgrowth induced by Yki overexpression whereas excess amounts of 14-3-3 suppressed Yki-induced overgrowth phenotype. In addition, 14-3-3 RNAi resulted in the accumulation of Yki in the nucleus. We provided both genetic and biochemical evidence that regulation of Yki by 14-3-3 is through phosphorylation of Yki at Ser168. Furthermore, we provided evidence that Hpo signaling inhibited Yki nuclear localization and activity through two additional phosphorylation sites, Ser111 and Ser250, and this regulation appeared to be 14-3-3 independent. Finally, we provided evidence that Yki subcellular localization is regulated by CRM1-mediated nuclear export.
Materials and methods

Mutants and transgenes
The 14-3-3ζ-RNAi transgene was obtained from VDRC (http:// www.vdrc.at/). 14-3-3ε j2B10 and 14-3-3ζ 12BL are strong loss-offunction alleles (http://flybase.org/). To construct UAS-14-3-3ε-RNAi transgenes, genomic DNA fragment corresponding to 14-3-3ε aa45-108 was amplified by PCR and subcloned between the BglII and KpnI sites of the pUAST vector. The corresponding cDNA fragment was inserted in a reverse orientation between KpnI and XbaI sites. Yki point mutations were generated by PCR-based site directed mutagenesis and verified by DNA sequence. The Yki coding sequence was amplified by PCR and subcloned in frame into the pUAST-6Myc vector (Zhang et al., 2008) . To construct wild-type and mutant forms of attB-UAS-MycYki transgenes , a pUAST vector with attB sequence inserted upstream of the UAS-binding sites was used (Liu et al., 2007) . The vas-phi-zh2A-VK5 flies were used to generate Yki transformants inserted at the 75B1 attP locus. To construct HA-14-3-3, 14-3-3 coding sequences were amplified by PCR and subcloned in frame into the pUAST-3HA vector (Zhang et al., 2008) .
Cell culture, transfection, immunoprecipitation, western blot analysis and luciferase reporter assay S2 cells were cultured in Drosophila Schneider's Medium (Invitrogen) with 10% fetal bovine serum, 100U/ml of penicillin, and 100ug/ ml of Streptomycin. Transfection was carried out using Calcium Phosphate Transfection Kit (Specialty Media) according to manufacturer's instructions. A ubiquitin-Gal4 construct was cotransfected with pUAST expression vectors for all the transfection experiments. Immunoprecipitation and western blot analysis were performed using standard protocols as previously described (Zhang et al., 2008) . Antibodies used were mouse anti-HA (Santa Cruz), mouse anti-Myc (Santa Cruz). For Luciferase reporter assays, S2 cells were transfected with 3 × Sd2-Luc and copia-renilla luciferase reporter constructs (Zhang et al., 2008) in 12-well plates together with constructs expressing Sd and different mutant forms of Yki. Cells were incubated for 48 h after transfection and the luciferase reporter assay was performed using the Dual-Luciferase reporter assay system (Promega). DualLuciferase measurements were performed in triplicate using FLUOstar OPTIMA (BMG LABETCH).
Immunostaining
Immunostaining of imaginal discs and cultured cells was carried out as described (Jia et al., 2004; Jiang and Struhl, 1995) . Antibodies or dyes used in this study were as follows: mouse anti-Myc (Santa Cruz), rabbit anti-HA (Santa Cruz), rabbit anti-Yki (Oh and Irvine, 2008 ) and 7-AAD (Molecular Probes). For LMB treatment of S2 cells, LMB was added at a concentration of 20 nM for 4 h before cells were collected.
Results
Knockdown of 14-3-3 enhances Yki-induced overgrowth
To investigate whether 14-3-3 proteins regulate Yki activity, we used transgenic RNAi technique (Kalidas and Smith, 2002; Kennerdell and Carthew, 2000) to knockdown either 14-3-3ɛ or 14-3-3ζ and examined whether reduction in 14-3-3 activity would modify Ykiinduced overgrowth phenotype. Overexpression of UAS-Yki posterior to the morphogenetic furrow (MF) using the GMR-Gal4 driver (referred to as GMR-Yki) resulted in enlarged eyes (Figs. 1B, B′) (Wu et al., 2008; Zhang et al., 2008) . Coexpression of either UAS-14-3-3ɛ-RNAi or UAS-14-3-3ζ-RNAi transgene enhanced the eye overgrowth phenotype (Figs. 1C-D′), whereas expression of neither RNAi transgene with GMR-Gal4 in otherwise wild-type eyes caused any visible phenotypes (data not shown). The effect of 14-3-3 RNAi on GMR-Yki is specific as 14-3-3 RNAi did not modify the overgrowth phenotype caused by expressing an active form of insulin receptor (data not shown).
To determine whether modification of the GMR-Yki phenotype was due to inactivation of 14-3-3 rather than off-target effects, we generated transgenes that express either 14-3-3ɛ or 14-3-3ζ under the control of the UAS promoter. As shown in Fig. 1 , enhancement of the GMR-Yki phenotype by 14-3-3ɛ RNAi was significantly suppressed by coexpression of UAS-14-3-3ζ (Figs. 1E and E′) but not by coexpression of UAS-14-3-3ɛ (Figs. 1F and F′). Similarly, coexpression of UAS-14-3-3ɛ but not UAS-14-3-3ζ suppressed the enhancement of GMR-Yki phenotype caused by 14-3-3ζ RNAi (Figs. 1G-H′). The isoform-specific rescue suggests that the transgenic RNAi for each isoform did not significantly interfere with the other isoform and that increasing the level of one 14-3-3 isoform could compensate for the loss of the other.
As an independent approach to determine whether loss of 14-3-3 would modulate Yki activity, we turned to loss-of-function mutations of 14-3-3. 14-3-3ɛ j2B10 and 14-3-3ζ 12BL are strong loss-of-function alleles of 14-3-3ɛ and 14-3-3ζ, respectively (flybase). We found that either 14-3-3ɛ j2B10 or 14-3-3ζ 12BL heterozygosity could enhance the GMR-Yki phenotype (Figs. 1J-K′). 14-3-3ɛ j2B10 and 14-3-3ζ 12BL double heterozygosity enhanced the GMR-Yki phenotype more profoundly (Figs. 1L and L′) . Taken together with the results from the RNAi experiments, these observations suggest that both 14-3-3 isoforms are involved in restricting Yki activity.
Overexpression of 14-3-3 suppresses Yki-induced overgrowth
We next investigated whether increasing the level of 14-3-3 could suppress the phenotype induced by GMR-Yki. UAS-Yki was coexpressed with two copies of either UAS-14-3-3ɛ, UAS-14-3-3ζ or both. We observed dose-dependent suppression of the GMR-Yki phenotype by 14-3-3 overexpression (Figs. 2B-E′). Overexpression of UAS-14-3-3ɛ and UAS-14-3-3ζ with GMR-Gal4 did not significantly affect eye GMR-Gal4 UAS-Yki (B and B′), GMR-Gal4 UAS-Yki; UAS-HA-14-3-3ε (C and C′), GMR-Gal4 UAS-Yki; UAS-HA-14-3-3ζ (D and D′), GMR-Gal4 UAS-Yki; UAS-HA-14-3-3ε+ UAS-HA-14-3-3ζ (E and E′) and GMR-Gal4; UAS-HA-14-3-3ε+ UAS-HA-14-3-3ζ (F and F′). , GMRGal4 UAS-Yki (B and B′), GMR-Gal4 UAS-Yki; UAS-14-3-3εRNAi (C and C′), GMR-Gal4 UAS-Yki; UAS-14-3-3ζRNAi (D and D′), GMR-Gal4 UAS-Yki; UAS-14-3-3εRNAi/ UAS-HA-14-3-3ζ (E and E′), GMR-Gal4 UAS-Yki; UAS-14-3-3εRNAi/UAS-HA-14-3-3ε (F and F′), GMR-Gal4 UAS-Yki; UAS-14-3-3ζRNAi/UAS-HA-14-3-3ε (G and G′), GMR-Gal4 UAS-Yki; UAS-14-3-3ζRNAi/ UAS-HA-14-3-3ζ (H and H′), GMR-Gal4 UAS-Yki (I and I′), GMR-Gal4 UAS-Yki; 14-3-3ε j2B10 /+ (J and J′), GMR-Gal4 UAS-Yki; 14-3-3ζ 12BL /+ (K and K′) and GMR-Gal4 UAS-Yki; 14-3-
/+ (L and L′). Reduction of 14-3-3 either by RNAi knockdown or loss-of-function mutations enhanced the overgrown phenotype caused by Yki overexpression.
development (Figs. 2F and F′) . Thus, both loss-of-function and gainof-function studies suggested that both 14-3-3 isoforms participate in restricting Yki activity.
Loss of 14-3-3 results in nuclear accumulation of Yki
To determine whether 14-3-3 regulates Yki activity by inhibiting its nuclear localization, we examined the subcellular localization of endogenous Yki in either wild-type wing discs or wing discs expressing both 14-3-3ɛ and 14-3-3ζ RNAi transgenes under the control of the wing-specific Gal4 driver MS1096. As 14-3-3 function is required for many cellular processes, a more complete loss of 14-3-3 could result in cell lethality. We therefore coexpressed a cell death inhibitor P35 (Hay et al., 1994) together with 14-3-3 RNAi transgenes to increase the survival of cells lacking 14-3-3 activity. Consistent with previous observations (Dong et al., 2007; Oh and Irvine, 2008) , the endogenous Yki was predominantly localized in the cytoplasm (Figs. 3A and B) . In 14-3-3 knockdown wing discs, Yki was accumulated in the nucleus (Figs. 3C-D″) , particularly in the dorsal compartment cells where MS1096-gal4 expression is higher (Wang et al., 1999) . These results demonstrated that 14-3-3 is required for the nuclear exclusion of Yki.
Yki activity is regulated by multiple phosphorylation events
It has been shown that Yap is regulated by phosphorylation at multiple sites that fall into the consensus sequence: HXRXXS (Hao et al., 2008; Zhao et al., 2007) . Besides Yki Ser168, which is equivalent to Yap Ser127, two additional sites (Ser111 and Ser250) fall into the same consensus (Fig. 6A) . To determine whether phosphorylation at Ser111 and Ser250 modulates Yki activity, we mutated them into Ala in otherwise wild-type background (Yki S111,250A ) or in the background where Ser168 was also mutated into Ala (Yki 3SA ). To directly compare their activities with those of wild-type Yki and Yki S168A without evoking the difference in the levels of transgene expression, transformants for Myc-tagged wild-type Yki (Myc-Yki) or Yki variants (Myc-Yki S168A , Myc-Yki S111,250A and Myc-Yki 3SA ) were generated using the phiC31 integration system to ensure that the transgenes were expressed at the same level (Bischof et al., 2007) . Consistent with our previous observation (Zhang et al., 2008) , Myc-Yki induced only modest overgrowth when expressed posterior to the MF using the GMR-Gal4 driver (Figs. 4A, A′) . In contrast, GMR-Myc-Yki S168A induced more dramatic eye overgrowth (Figs. 4B, B′) . Interestingly, GMR-Myc-Yki S111,250A also induced enlarged eyes although the phenotype was weaker than that of GMR-Myc-Yki S168A but stronger than GMR-Myc-Yki (Figs. 4C, C′) . Finally, Myc-Yki 3SA appeared to be more potent than Myc-Yki S168A as it induced more profound overgrowth than Myc-Yki S168A when expressed using GMR-Gal4 (Figs. 4D, D′) . As all the transgenes were inserted into the same chromosomal location and expected to express at comparable levels, the difference in the overgrowth phenotypes induced by different forms of Yki reflected the difference in their activities.
To further confirm that Yki activity is regulated by multiple phosphorylation events, we directly measured the activity of Yki variants using the sd-luciferase reporter assay (Zhang et al., 2008) . As shown in Fig. 4E , Yki variants exhibited higher activity than the wild-type Yki with the order of Yki 3SA N Yki S168A N Yki S111,250A N Yki WT , which is consistent with the in vivo activity exhibited by these Yki variants. In addition, Yki variants were more resistant to Hpomediated inhibition. Taken together, these results demonstrated that, besides phosphorylation at S168, phosphorylation at S111 and S250 also inhibited Yki activity, albeit to a lesser extent than S168 phosphorylation.
Regulation of Yki subcellular localization by phosphorylation at S111 and S250
It has been shown that Hpo signaling inhibits Yki nuclear localization by phosphorylating Yki at S168 (Dong et al., 2007; Oh and Irvine, 2008; Zhang et al., 2008) . To investigate whether phosphorylation at S111 and S250 also modulated Yki nuclear localization, we examined the subcellular localization of Yki S111,250A in S2 cells and wing disc cells. We have shown previously that Sd facilitates Yki nuclear localization in both S2 cells and wing imaginal discs (Zhang et al., 2008) . In agreement with these previous findings, Myc-Yki WT exhibited significant nuclear signal when coexpressed with HA-Sd but was excluded from the nucleus in the presence of Flag-Hpo coexpression (Figs. 5A, A′) . In contrast, Myc-Yki S168A exhibited more profound nuclear localization than Myc-Yki WT when coexpressed with HA-Sd and a significant portion of Myc-Yki S168A remained in the nucleus when Flag-Hpo was coexpressed (Figs. 5B, B′) . MycYki S111,250A also exhibited higher levels of nuclear signal than MycYki WT and nuclear Yki S111,250A signal was readily detectable when FlagHpo was coexpressed (Figs. 5C, C′) . However, the levels of nuclear Myc-Yki S111,250A appeared to be lower than those of Myc-Yki S168A (cf. Fig. 5C with Fig. 5B , also see Fig. 6C and Fig. 7 for quantification) . Finally, Myc-Yki 3SA was predominantly localized in the nucleus when coexpressed with HA-Sd and the majority of Myc-Yki 3SA remained in the nucleus even when Flag-Hpo was coexpressed (Figs. 5D, D′) .
We observed a similar trend of nuclear localization of Yki variants in wing imaginal discs. When coexpressed with HA-Sd using the MS1096 Gal4 driver, Myc-Yki S111,250A exhibited increased nuclear localization as compare with Myc-Yki WT (cf. Fig. 5G with Fig. 5E ) whereas both MycYki S168A and Myc-Yki 3SA were predominantly nuclear (Figs. 5F, H) . Thus, mutating S111 and S250 facilitated Yki nuclear localization, albeit less dramatically compared with S168A mutation.
Regulation of Yki subcellular localization by 14-3-3 is mediated by phosphorylation at S168 but is independent of phosphorylation at S111 and S250
Phosphorylation of YkiS168/YapS127 generates a 14-3-3 binding site that fall into the consensus RXXS p XP (Dong et al., 2007; Oh and Irvine, 2008; Zhao et al., 2007) . In contrast, phosphorylation at S111 or S250 does not generate a 14-3-3 binding consensus site because a critical Pro residue C-terminal to the phospho-Ser residue is missing (Fig. 6A) , implying that regulation of Yki by these two phosphorylation sites is 14-3-3 independent. To confirm that phosphorylation at Ser111 and 250 does not render 14-3-3 binding, we carried out immunoprecipitation experiments to determine the interaction between 14-3-3 with various Yki mutants. As shown in Fig. 6 , HA-14-3-3 was coimmunoprecipitated with Myc-Yki WT and the interaction between 14-3-3 and Myc-Yki WT increased dramatically when the Hpo/Wts/Mats complex was coexpressed (Fig. 6B, lanes 1 and 5) . Mutating S111 and S250 did not affect either the basal or Hpo signaling-induced 14-3-3 binding (Fig. 6B, lanes 3 and 7) . In contrast, mutating S168 completely abolished both the basal and Hpo signalinginduced 14-3-3 binding (Fig. 6B, lanes 2 and 6) . Myc-Yki 3SA and MycYki S168A behaved similarly with respect to 14-3-3 binding (cf. lanes 4 and 8 with lanes 2 and 6). Consistent with the observations that phosphorylation at S168 but not at S111 and S250 promotes 14-3-3 binding, Hpo-mediated inhibition of Myc-Yki S111,250A nuclear localization was enhanced by coexpression of 14-3-3 in S2 cells (Fig. 6C) . In contrast, Hpo-mediated inhibition of Myc-Yki S168A nuclear localization was not significantly affected by 14-3-3 coexpression. Thus, phosphorylation at S111 and S250 does not regulate Yki/14-3-3 association and nuclear restriction of Yki by 14-3-3.
In corroboration with the observations obtained in S2 cells, 14-3-3 cooperated with the Hpo kinase domain (HpoN) to inhibit the overgrowth phenotypes caused by overexpression of Yki or Yki S111,250A (Figs. 6D-D″ and E-E″). In contrast, 14-3-3 did not collaborate with HpoN to suppress the overgrowth phenotypes caused by overexpression of Yki S168A or Yki 3SA (Figs. 6F-F″ and G-G″) . Furthermore, the overgrowth phenotype induced by Yki S111,250A overexpression was consistently enhanced by 14-3-3 knockdown (Figs. S1C-D′). In contrast, the overgrowth phenotype caused by Yki S168A or Yki 3SA was not significantly enhanced by 14-3-3 knockdown (Figs. S1A-B′ and E-F′). These observations strength the view that 14-3-3 regulates Yki activity through phosphorylation at S168 whereas phosphorylation at S111 and S250 regulates Yki activity independent of 14-3-3.
Phosphorylation of Yki does not regulate Ex-mediated inhibition of Yki
It has been shown recently that Ex directly binds Yki and inhibits its nuclear localization and activity (Badouel et al., 2009) . We found that Ex inhibited the activity of Myc-Yki WT , Myc-Yki S111,250A , MycYki S168A and Myc-Yki 3SA in the sd-luciferase reporter assay (Fig. S2A) . In addition, mutating S111, S168 and S250 did not affect cytoplasmic sequestration of Yki by Ex (Fig. S2B) , suggesting that phosphorylation of Yki at S111, S168 and S250 as well as 14-3-3 binding is not required for Ex-mediated inhibition of Yki.
Regulation of Yki subcellular localization by CRM1-mediated nuclear export
Hpo signaling could prevent Yki nuclear localization by impeding its nuclear import or by promoting its nuclear export. To investigate whether Yki is regulated by nuclear export, we treated cells transfected with Yki and Sd expression constructs with leptomycin B (LMB), a drug that blocks CRM1-dependent nuclear export (Kudo Fig. 6 . Phosphorylation at S111 and S250 regulates Yki independent of 14-3-3. (A) The alignment of Yki sequences surrounding S111, S168 or S250 with the consensus sequence for Wts phosphorylation site indicated underneath. X: any amino acid. (B) Mutating S111 and S250 does not affect 14-3-3 binding but mutating S168 abolishes 14-3-3 binding. S2 cells were transfected with indicated Myc-tagged wild-type and mutant Yki constructs and HA-14-3-3 constructs with or without Hpo/Wts/Mats coexpression, followed by immunoprecipitation and western blot analyses with indicated antibodies. (C) 14-3-3 regulates nuclear localization of Yki S111,250A but not Yki S168A . S2 cells were transfected with HA-SD, Myc-Yki S111,250A or Myc-Yki S168A , without or with coexpression of Hpo or Hpo plus 14-3-3. Cells were immunostained with Myc and HA antibodies, and the subcellular localization of Myc-Yki S111,250A or Myc-Yki S168A was monitored using confocal microscopy. Cells with different nucleocytoplasmic distributions of Myc-tagged Yki were counted. A total of 100 cells were counted for each Yki construct. C N N: cells contain higher levels of Yki in the cytoplasm than in the nucleus. C = N: cells contain Yki equally distributed in cytoplasm and nucleus. N N C: cells contain higher levels of Yki in the nucleus than in the cytoplasm. The y axis indicates the percentage of cells in each category. (D-G″) Side (top) or dorsal (bottom) views of adult eyes expressing GMR-Gal4 UAS-Yki (D), GMR-Gal4 UAS-Yki S111,250A (E), GMR-Gal4 UAS-Yki S168A (F) or GMR-Gal4 UAS-Yki 3SA (G). HpoN (D′-G′) or HpoN and 14-3-3 (D″-G″) were coexpressed with the wild-type or mutant Yki as indicated. et al., 1998), and determined if blocking nuclear export affect Yki subcellular localization. In the absence of LMB treatment, the majority of cells (∼70%, N = 100) exhibited higher levels of Myc-Yki WT in the cytoplasm whereas only a small fraction of cells (∼30%, N = 100) exhibited equal distribution of Myc-Yki WT in the cytoplasm and nucleus or higher levels of Myc-Yki WT in the nucleus. Strikingly, after LMB treatment, the majority of cells ( N 80%, N = 100) exhibited equal distribution of Myc-Yki WT in the cytoplasm and nucleus or higher levels of nuclear Myc-Yki WT (Fig. 7A) . In the presence of Flag-Hpo, N90% (N = 100) of cells exhibited exclusive cytoplasmic Myc-Yki WT in the absence of LMB, whereas after LMB treatment, about 50% of cells (N = 100) exhibited higher nuclear signals or equal distribution of nuclear and cytoplasmic signals of Myc-Yki WT (Fig. 7A) . LMB treatment also promoted nuclear localization of Myc-Yki S111,250A , Myc-Yki S168A and Myc-Yki 3SA and interfered with Hpo-mediated cytoplasmic retention of these Yki variants (Figs. 7B-D) . In contrast, Ex sequestered both Myc-Yki WT and Myc-Yki 3SA in the cytoplasm efficiently in the presence of LMB treatment (Fig. S3) . Thus, phosphorylation-mediated inhibition of Yki nuclear localization critically depends on nuclear export whereas Ex/Yki interaction inhibits Yki nuclear localization is independent of Yki nuclear export.
Discussion
The Hpo pathway is an evolutionarily conserved pathway that regulates cell growth, cell proliferation and apoptosis. The transcriptional coactivator Yki/YAP is the critical downstream regulatory target of the Hpo kinase cascade. It has been suggested that regulation of the subcellular localization of Yki/Yap is the primary mechanism by which the Hpo pathway influences gene expression (Pan, 2007; Zhang et al., 2009) . The observation that Hpo signaling regulates Yki nuclear localization by phosphorylating S168 and phosphorylation at S168 promotes 14-3-3 binding led to the proposal that Hpo signalingmediated phosphorylation of Yki at S168 sequesters Yki in the cytoplasm through 14-3-3 binding. Here we provide genetic evidence that 14-3-3 inhibits Yki nuclear localization and restricts Yki activity.
As complete loss of 14-3-3 leads to cell lethality due to the essential roles of 14-3-3 in many cellular processes, we applied RNAi to partially inactivate 14-3-3 and asked whether Yki activity was potentiated. Indeed, we found that knockdown of either 14-3-3ɛ or 14-3-3ζ enhanced the overgrowth phenotype induced by GMR-Yki (Figs. 1C-D′) . In addition, removal of one copy of either 14-3-3ɛ or 14-3-3ζ slightly enhanced the GMR-Yki phenotype whereas removal of one copy of both 14-3-3ɛ and 14-3-3ζ resulted in a more dramatic enhancement of the GMR-Yki phenotype (Figs. 1J-L′) . On the other hand, overexpressing either 14-3-3ɛ or 14-3-3ζ can suppress the GMR-Yki phenotype (Fig. 2) . Thus, both loss-of-function and gain-offunction studies suggest that both 14-3-3 isoforms participate in restricting Yki activity. Furthermore, we found that knockdown of 14-3-3 led to nuclear accumulation of endogenous Yki in wing imaginal disc cells (Fig. 3) , suggesting that 14-3-3 inhibits Yki activity by restricting its nuclear localization. Hpo signaling restricts Yki nuclear localization and activity by phosphorylating Yki at S168, which is equivalent to S127 of Yap. Phosphorylation at YkiS168/Yap S127 generates 14-3-3 binding site. Consistent with phosphorylation at this site inhibits Yki nuclear localization and activity through 14-3-3 binding, we found that the activity of Yki S168A was not sensitive to changes in 14-3-3 activity as RNAi knockdown or overexpression of 14-3-3 did not significantly modulate the overgrowth phenotype caused by GMR-Yki S168A (Figs.  6F-F″; Figs. S1A-B′) . Moreover, the subcellular localization of Yki S168A was not influenced by overexpression of 14-3-3 (Fig. 6C ). Taken together with the biochemical data, these observations suggest that 14-3-3 regulates Yki nuclear localization and activity through interaction with phosphorylated Yki at S168.
Although phosphorylation at YkiS168 is a major regulatory mechanism of Yki nuclear localization and activity, it is not the only mechanism. Two previous studies revealed that Yap was phosphorylated at 4 additional sites that conform the consensus sequence, HXRXXS, and that phosphorylation at these sites also inhibited Yap activity (Hao et al., 2008; Zhao et al., 2007) . We found that Yki has two additional sites that match the same consensus, HSRANS 111 AD and HKKQRS 250 YN (Fig. 6A) . Interestingly, mutating Ser 111 and S250 to A (Yki S111,250A ) increased Yki activity (cf. Fig. 4C with Fig. 4A ) and rendered Yki less sensitive to Hpo/Wts-mediated inhibition (Fig. 4E) . Compared with wild-type Yki, Yki S111,250A exhibited increased levels of nuclear localization in both S2 cells and wing discs (Figs. 5C and G; cf. Fig. 5A with Fig. 5E ). Yki S111,250A appears to be less potent in inducing overgrowth as compared Yki S168A (Fig. 4) . Consistently, nuclear localization of Yki S111,250A was less profound than that of Yki S168A (Fig. 5) . Finally, Ser 111 and S250 to A mutation had an additive effect with S168 mutation as Yki 3SA exhibited the highest levels of activity and more profound nuclear localization than Yki S168A or Yki S111,250A , suggesting that these phosphorylation events act in parallel to inhibit Yki nuclear localization and activity. In agreement with our findings, Oh and Irvine (2009) also observed that mutating Yki S111 and S250 enhanced Yki subcellular localization and activity and rendered Yki less sensitive to Hpo/Wts-mediated inhibition.
Mutating Yki S111 and S250 (Yki S111,250A ) did not affect 14-3-3 binding to Yki and phosphorylation at these two sites in the absence of S168 (Yki S168A ) failed to confer any detectable Yki/14-3-3 association ( Fig. 6B ; Oh and Irvine, 2009) . Furthermore, when S127 of Yap was mutated, phosphorylation at other 4 sites failed to recruit 14-3-3 (Hao et al., 2008; Zhao et al., 2007) . Consistent with these biochemical data, we found that Yki S168A , which has intact S111 and S250, was insensitive to either gain or loss of 14-3-3 activity. On the other hand, Yki lacking Ser 111 and S250 (Yki S111,250A ) was still inhibited by 14-3-3. These observations support the view that phosphorylation at Ser 111 and S250 may regulate Yki nuclear localization and activity independent of 14-3-3 association. A recent study has revealed that Ex can physically associate with Yki and this interaction appears to sequester Yki in the cytoplasm. We found that Ex not only sequestered the wild-type Yki but also the phosphorylation deficient forms of Yki (Fig. S2) , suggesting that regulation of Yki nuclear localization by phosphorylation at Ser 111 and S250 is unlikely mediated by Ex.
How phosphorylation and 14-3-3 binding regulate Yki nuclear localization is not clear but it appears that nuclear export is required for restricting Yki nuclear localization in response to Hpo signaling (Fig. 7) . Bind of 14-3-3 to target proteins has been suggested to regulate nucleocytoplasmic shuttling by impeding nuclear import and/or promoting nuclear export (Brunet et al., 2002; Kumagai and Dunphy, 1999) . Yki does not have an intrinsic nuclear localization signal (NLS) and its nuclear import appears to depend on its binding partner Sd (Goulev et al., 2008; Zhang et al., 2008) . It is not impossible that binding of 14-3-3 to Yki could mask the NLS of Sd. An alternative but not mutually exclusive model is that phosphorylation and 14-3-3 binding may facilitate CRM1-mediated nuclear export. Consistent with this model, we found that blocking CRM1-mediated nuclear export by LMB treatment effectively prevented cytoplasmic localization in response to Hpo signaling. However, since the nuclear levels of Yki S168A and Yki 3SA increased after LMB treatment, Yki can be exported out of the nucleus even in the absence of Yki phosphorylation and 14-3-3 binding. Thus, phosphorylation and 14-3-3 binding is not absolutely required for but may facilitate Yki nuclear export. In contrast, Ex-mediated cytoplasmic localization of Yki was not effectively blocked by LMB treatment (Fig. S3) , suggesting that Ex/ Yki interaction may sequester Yki in the cytoplasm independent of nuclear export. Since Ex can effectively retain Yki S168A and Yki 3SA in the cytoplasm and both Yki S168A and Yki 3SA no longer bind 14-3-3, the regulation of Yki by Ex is likely to be 14-3-3 independent.
CRM1 mediates nuclear export of target proteins through nuclear export signal (NES) (Fornerod et al., 1997; Fukuda et al., 1997) . Inspection of Yki and Yap sequences identified multiple NES like sequences (our unpublished observation). It will be interesting to determine the roles of these putative NES sequences in regulating Yki/Yap subcellular localization and activity and how 14-3-3 proteins control the nucleocytoplasmic shuttling of Yki/Yap. We also note that the subcellular localization and activity of Yki 3SA is still regulated by Hpo signaling, albeit much less effectively as compared with the wildtype Yki. Similar observation has been made for the phosphorylation deficient form of Yap that lacks all the Wts phosphorylation sites (Zhao et al., 2007) . Thus, Hpo signaling may regulate Yki through additional mechanism(s) independent of its phosphorylation.
